REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,075,979 | -44.3% | 355,360 | +23.0% | 0.14% | -35.6% |
Q2 2023 | $7,312,742 | -6.7% | 288,927 | +18.7% | 0.22% | -5.9% |
Q1 2023 | $7,841,911 | +22.0% | 243,462 | -30.1% | 0.24% | +21.9% |
Q4 2022 | $6,425,261 | -2.8% | 348,064 | +42.1% | 0.20% | -9.3% |
Q3 2022 | $6,613,000 | +113.9% | 244,917 | +9.5% | 0.22% | +103.8% |
Q2 2022 | $3,091,000 | -2.0% | 223,631 | +38.3% | 0.11% | +35.9% |
Q1 2022 | $3,153,000 | -10.8% | 161,695 | -25.3% | 0.08% | +6.8% |
Q4 2021 | $3,533,000 | -1.1% | 216,497 | +68.8% | 0.07% | +7.4% |
Q3 2021 | $3,573,000 | – | 128,239 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,228,609 | $59,972,145 | 5.67% |
Essex Woodlands Management, Inc. | 457,085 | $5,242,765 | 4.62% |
Ghost Tree Capital, LLC | 350,000 | $4,014,500 | 1.32% |
AlphaCentric Advisors LLC | 190,000 | $2,179,300 | 1.24% |
Sio Capital Management, LLC | 342,477 | $3,928,211 | 1.22% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 288,726 | $3,308,800 | 1.12% |
Rubric Capital Management LP | 1,600,000 | $18,352,000 | 0.69% |
RICE HALL JAMES & ASSOCIATES, LLC | 683,937 | $7,844,757 | 0.50% |
Rhenman & Partners Asset Management AB | 361,679 | $4,148,458 | 0.45% |
Polar Capital Holdings Plc | 4,160,311 | $47,718,767 | 0.35% |